154 related articles for article (PubMed ID: 37866793)
1. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
[TBL] [Abstract][Full Text] [Related]
2. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
[TBL] [Abstract][Full Text] [Related]
3. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
[TBL] [Abstract][Full Text] [Related]
4. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
[TBL] [Abstract][Full Text] [Related]
5. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and early kidney function decline in young adults: a longitudinal analysis of the CARDIA (Coronary Artery Risk Development in Young Adults) study.
Grubbs V; Lin F; Vittinghoff E; Shlipak MG; Peralta CA; Bansal N; Jacobs DR; Siscovick DS; Lewis CE; Bibbins-Domingo K
Am J Kidney Dis; 2014 Apr; 63(4):590-7. PubMed ID: 24295611
[TBL] [Abstract][Full Text] [Related]
7. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
[TBL] [Abstract][Full Text] [Related]
8. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
[TBL] [Abstract][Full Text] [Related]
9. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
Chen DC; Lu K; Scherzer R; Lees JS; Rutherford E; Mark PB; Potok OA; Rifkin DE; Ix JH; Shlipak MG; Estrella MM
Kidney Med; 2024 Apr; 6(4):100796. PubMed ID: 38567244
[TBL] [Abstract][Full Text] [Related]
12. Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality.
O'Seaghdha CM; Tin A; Yang Q; Katz R; Liu Y; Harris T; Astor B; Coresh J; Fox CS; Kao WH; Shlipak MG
Am J Kidney Dis; 2014 Jan; 63(1):16-22. PubMed ID: 23932088
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.
Scheppach JB; Coresh J; Wu A; Gottesman RF; Mosley TH; Knopman DS; Grams ME; Sharrett AR; Koton S
Am J Kidney Dis; 2020 Dec; 76(6):775-783. PubMed ID: 32428540
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
Lees JS; Rutherford E; Stevens KI; Chen DC; Scherzer R; Estrella MM; Sullivan MK; Ebert N; Mark PB; Shlipak MG
JAMA Netw Open; 2022 Oct; 5(10):e2238300. PubMed ID: 36282503
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies between Cystatin C-Based and Creatinine-Based eGFR.
Farrington DK; Surapaneni A; Matsushita K; Seegmiller JC; Coresh J; Grams ME
Clin J Am Soc Nephrol; 2023 Sep; 18(9):1143-1152. PubMed ID: 37339177
[TBL] [Abstract][Full Text] [Related]
16. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.
Husain SA; Willey JZ; Park Moon Y; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
PLoS One; 2018; 13(11):e0206839. PubMed ID: 30427947
[TBL] [Abstract][Full Text] [Related]
17. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
Wang J; Liu Y; Jin R; Zhao X; Wu Z; Han Z; Xu Z; Guo X; Tao L
Nephrol Dial Transplant; 2024 Apr; 39(5):860-872. PubMed ID: 37930847
[TBL] [Abstract][Full Text] [Related]
18. Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study.
Ballew SH; Chen Y; Daya NR; Godino JG; Windham BG; McAdams-DeMarco M; Coresh J; Selvin E; Grams ME
Am J Kidney Dis; 2017 Feb; 69(2):228-236. PubMed ID: 27884475
[TBL] [Abstract][Full Text] [Related]
19. Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m
Malkina A; Katz R; Shlipak MG; Ix JH; de Boer IH; Sarnak MJ; Allison M; Kramer HJ; Lin J; Siscovick D; Peralta CA
Open J Endocr Metab Dis; 2013 May; 3(2):103-112. PubMed ID: 25210651
[TBL] [Abstract][Full Text] [Related]
20. A Risk Score to Guide Cystatin C Testing to Detect Occult-Reduced Estimated Glomerular Filtration Rate.
Peralta CA; Muntner P; Scherzer R; Judd S; Cushman M; Shlipak MG
Am J Nephrol; 2015; 42(2):141-7. PubMed ID: 26381887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
